Digital Health News | pharmaphorum

News

FDA ramps up its pushback against compounded GLP-1s

In a move that will please Novo Nordisk and Eli Lilly, the FDA sent warnings to 30 telehealth firms, accusing them of illegally marketing GLP-1 drugs.

News

Generate's IPO gets over the line, raising $400m

AI-powered drug developer Generate Biomedicine completes a $400m IPO, the largest for biotech on the Nasdaq so far this year.

News

Eisai unveils digital platform for kidney cancer patients

Eisai has launched a 'digital destination', called Kompass, that aims to support patients after they have been given a diagnosis of kidney cancer.

News

Patients struggling with NHS complexity, says report

For patients and GPs, accessing NHS services can feel like a "maze of dead ends and detours," according to a new poll.

News

Hims & Hers buys Australian digital health firm for $1.15bn

Hims & Hers, facing a threat to its compounded medicines business, has ramped up its push for international expansion by buying Eucalyptus Health.

News

MSD and Mayo Clinic team up on AI drug discovery

MSD has signed an industry-first deal with the Mayo Clinic that will allow it to use the health system's genomic and clinical data for drug discovery.

FDA ramps up its pushback against compounded GLP-1s

Generate's IPO gets over the line, raising $400m

Eisai unveils digital platform for kidney cancer patients

Patients struggling with NHS complexity, says report

Hims & Hers buys Australian digital health firm for $1.15bn

MSD and Mayo Clinic team up on AI drug discovery

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks